Navigation Links
Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
Date:9/17/2007

Loutit Brings Significant Experience in Pulmonary and Infectious Disease

Drug Development

SAN DIEGO, Sept. 17 /PRNewswire/ -- Mpex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing products to overcome issues of antibiotic resistance, today announced the appointment of Dr. Jeffery Loutit as the Company's Chief Medical Officer. Dr. Loutit joins Mpex from InterMune, Inc. where since 2001 he has held positions of increasing responsibility and most recently was Vice President of Clinical Science. At InterMune he led multiple Phase 1-3 clinical trials, including two global Phase 3 trials for pirfenidone in patients with idiopathic pulmonary fibrosis. In addition, he negotiated pivotal trial designs for pirfenidone with US and European regulatory agencies and led the late stage clinical development of the anti-infective compound oritavancin, which was subsequently successfully out-licensed.

Prior to entering industry, Dr. Loutit was Chief of the Infectious Diseases Section, Veterans Administration Health Care System in Palo Alto and Assistant Professor of Medicine, Stanford University Medical School, where he published extensively in the area of infectious disease. He received his medical and microbiology degrees from Otago University in New Zealand and is board certified in the US in both infectious disease and internal medicine.

"We believe Jeff will be a great addition to our senior management," said Daniel Burgess, President & CEO of Mpex Pharmaceuticals. "His distinguished reputation and extensive early and late-stage trial experience will be a perfect complement to our scientific and clinical team as we advance our drug candidates. In particular, his protocol design background in both pulmonary and infectious disease medicine is ideally suited to leading our development efforts for MP-376, an agent being developed for the treatment of chronic respiratory infections in patie
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Wisconsin IT association names Gee president, CEO
4. Quintessence Biosciences names new president
5. CDW names VP to handle Berbee merger
6. NimbleGen names CFO with capital-raising past
7. Cisco names Berbee a top partner of 2005
8. Cisco names Inacom most innovative partner
9. UW-Madison medical school names new dean
10. GE Healthcare names new CEO
11. Bruker AXS names new leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ew hire brings over 20 years of commercial life sc...AN DIEGO, Nov. 21 Cyntellect, a pr...elopment and commercialization of live cell analys...it has appointed Andre Lubarsky as the Company,s D...sponsible for the sales of Cyntellect,s cell purif...
(Date:11/21/2008)...AN DIEGO, Nov. 21 Gen-Pr...ssay may be an important new molecular tool to mor...s (HPV) infections that are,associated with cervi...ine,oral presentations and two scientific posters... researchers at the international conference of th...
(Date:11/20/2008)...ADISON, N.J., Nov. 20 Wy...amarck, Ph.D., 57, has been promoted to President,...p;PS). Dr. Kamarck will be,responsible for all a...for,Wyeth, including its Pharmaceutical, BioPharm...nits. He succeeds Charles Portwood, 58, who has b...
(Date:11/20/2008)...AN DIEGO, Nov. 20 Neuroc...d today that Kevin Gorman, President and Chief,Ex...presenting at the 20th,Annual Piper Jaffray Healt...fireside chat" presentation takes place Tuesday, D...0:30 a.m. Pacific Time (PT). The,presentation wil...
Breaking Biology Technology:Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America 2Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 2Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 3Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 5Wyeth Names Michael Kamarck President, Technical Operations & Product Supply 2
... - The North Eastern Wisconsin Public Safety Commu...00 Federal Homeland Security grant to help public ...rding to Gov. Jim Doyle. , ,The funds will be use...io plan for the 16-county group, and purchase equi...t and fire agencies to communicate with one anothe...
... - The University of Wisconsin-Platteville will ...nline certificate program offered by the Universit... announced on Wednesday. , ,The Project Management...ss to online career training and education program...UC Irvine Extension,s program was designed in resp...
...Third Wave Technologies , a developer and marketer...hursday that it has won a patent infringement laws...veloper based in La Jolla, Calif. , ,The decision,...States District Court for the Western District of ...city reagents had infringed on two patents held by...
...One of the greatest agricultural and evolutionary ...answer may lie in a plot of corn on the western ed...to ancient genetic material. , ,While many biologi...the progenitor of maize, others believe that the d...lex to have arisen through natural mutation or hum...
Other Biology Technology:Third Wave wins patent lawsuit against California firm 2Single gene controls key difference between maize and its wild ancestor 2Single gene controls key difference between maize and its wild ancestor 3
(Date:11/20/2008)...le in German . , Halle/Saale. For the firs...verview of which alien species are present in Euro...ment and society. More than 11,000 alien species h...vasive Species Inventory for Europe), a unique thr...an scientists, funded by the European Union that p...
(Date:11/20/2008)...g it. It is relentless and terminal. Auguries and ... and science fiction writers, researchers and plas...in the pursuits of "turning back the clock." Yet, ...to our name, at most. , Technological wizardry ... span still elude us? , If you ask Arizona Stat...
(Date:11/19/2008)...al Academy of Sciences (NAS) announced today the c...," an initiative designed to connect entertainment...gineers to help the creators of television shows, ...ate science into their work. The Exchange represe... to the entertainment community and provide the cr...
(Date:11/19/2008)...since the ancient thinker Archimedes shouted "Eure...pill out, scientist though the ages have solved ma...low. Today, the field of fluid dynamics addresses ...ronomy, engineering, alternative energy, and medic...ing of the year devoted to the dynamics of fluids ...
Breaking Biology News(10 mins):11,000 alien species invade Europe 2Fountain of Youth to be found in the anthill? 2Fountain of Youth to be found in the anthill? 3Fountain of Youth to be found in the anthill? 4NAS announces initiative to connect entertainment industry with top experts 2NAS announces initiative to connect entertainment industry with top experts 3Jupiter's shrinking red spot 2Jupiter's shrinking red spot 3Jupiter's shrinking red spot 4Jupiter's shrinking red spot 5Jupiter's shrinking red spot 6Jupiter's shrinking red spot 7Jupiter's shrinking red spot 8Jupiter's shrinking red spot 9Jupiter's shrinking red spot 10Anesiva and Sigma Tau Announce Exclusive Marketing and Distribution Agreement for Zingo 28TM 29 in Six European Countries 11562 1Anesiva and Sigma Tau Announce Exclusive Marketing and Distribution Agreement for Zingo 28TM 29 in Six European Countries 11562 2Anesiva and Sigma Tau Announce Exclusive Marketing and Distribution Agreement for Zingo 28TM 29 in Six European Countries 11562 3Mesa Labs Reports Higher Quarterly Sales and Earnings 11559 1Mesa Labs Reports Higher Quarterly Sales and Earnings 11559 2Mesa Labs Reports Higher Quarterly Sales and Earnings 11559 3Mesa Labs Reports Higher Quarterly Sales and Earnings 11559 4Mesa Labs Reports Higher Quarterly Sales and Earnings 11559 5Anesiva Announces Fourth Quarter and Year End 2007 Financial Results and Provides 2008 Outlook 3192 1Anesiva Announces Fourth Quarter and Year End 2007 Financial Results and Provides 2008 Outlook 3192 2Anesiva Announces Fourth Quarter and Year End 2007 Financial Results and Provides 2008 Outlook 3192 3Anesiva Announces Fourth Quarter and Year End 2007 Financial Results and Provides 2008 Outlook 3192 4Anesiva Announces Fourth Quarter and Year End 2007 Financial Results and Provides 2008 Outlook 3192 5Anesiva Announces Fourth Quarter and Year End 2007 Financial Results and Provides 2008 Outlook 3192 6Anesiva Announces Fourth Quarter and Year End 2007 Financial Results and Provides 2008 Outlook 3192 7Anesiva Announces Fourth Quarter and Year End 2007 Financial Results and Provides 2008 Outlook 3192 8Anesiva Announces Fourth Quarter and Year End 2007 Financial Results and Provides 2008 Outlook 3192 9Most With High Blood Pressure Dont Follow Recommended Diet 11558 1Most With High Blood Pressure Dont Follow Recommended Diet 11558 2
...d gelling agent in making jams and jellies, but it... instance, and may have a role in important biolog...ent and defense against disease. , Despite the imp...ary walls of plants, scientists have known relativ...ccharides is made. Especially perplexing has been ...
...e most complex in the animal kingdom. Researchers ... their own syntax that uses sound units to build p...t for hours. , Until now, only humans have demonst...ture of communication. The research, published onl...Acoustical Society of America, offers a new approa...
...resurgence of malaria in the East African Highland...o said no, but new research by an international te...l ecologist Mercedes Pascual finds that, while oth...changing land use patterns and human migration als...ut. , "Our results do not mean that temperature i...
...niversity have developed a novel orally administer...n cell inflammation and neuron loss associated wit...dly absorbed by the brain and is non-toxic ?import...ug that might need to be taken for extended period...rnal of Neuroscience, the compound, called MW01-5-...
Other Biology News:Discovery of new molecular tools for biosynthesis could lead to advances in use of pectin 2Discovery of new molecular tools for biosynthesis could lead to advances in use of pectin 3Warbling whales speak a language all their own 2Warbling whales speak a language all their own 3Warming trend may contribute to malaria's rise 2New compound stops brain cell degeneration in Alzheimer's disease 2New compound stops brain cell degeneration in Alzheimer's disease 3
11-keto Testosterone EIA Antiserum hormones steroids antisera antiserum eias enzyme immunoassays reagents 11-keto-testosterone
Rabbit polyclonal to MKK6 (phospho S207) ( Abpromise for all tested applications). Antigen: Synthetic phosphopeptide derived from human MKK6 around the phosphorylation site of Serine 207 (V-D-S
Anti-human L-Ficolin, Clone GN4, Monoclonal Antibody
14-3-3 tau Antibody Shipping Temperature: HOT Storage Temperature: -20C
Biology Products: